טמו 180 מ"ג

Země: Izrael

Jazyk: hebrejština

Zdroj: Ministry of Health

Aktivní složka:

TEMOZOLOMIDE 180 MG

Dostupné s:

PERRIGO ISRAEL AGENCIES LTD

ATC kód:

L01AX03

Léková forma:

CAPSULES

Podání:

PER OS

Výrobce:

HAUPT PHARMA AMAREG GMBH, GERMANY

Terapeutické skupiny:

TEMOZOLOMIDE

Terapeutické indikace:

Temo capsules are indicated for the treatment of patients with malignant glioma such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy. Temo capsules are also indicated as first line treatment for patients with advanced metastatic malignant melanoma. Newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment.

Datum autorizace:

2011-11-01